Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0QXX stock hub

LON/0QXX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QXXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

114.1M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QXX

In the news

Latest news · LON/0QXX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-55.5

P25 -54.2P50 2.1P75 13.7

ROIC-30.4

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QXX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

151

Groups with data

Currency

CHF

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	134
Employees Change	-5.5%
Employees Change Percent	-3.47
Enterprise value	CHF 29.7M
Exchange	London Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	CH0256379097
Last refreshed	2026-05-10
Market cap	CHF 114.1M
Price	CHF 3.23
Price currency	CHF
Sector	Healthcare
Sic	2836
Symbol	lon/0QXX
Website	https://www.molecularpartners.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-50.65%
EV Earnings	-0.51x
EV/FCF	-0.61x
FCF yield	-42.7%
P/B ratio	1.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	CHF -36.7M
Net Income	CHF -57.8M
Net Income Growth Years	0%
Profit Per Employee	CHF -431,100
ROA	-26.59
Roa5y	-10.62
ROCE	-60.86
ROE	-55.55
Roe5y	-22.06
ROIC	-30.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-5.97%
Cagr3y	-19.09%
Cagr5y	-31.75%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CHF 95.7M
Cash	CHF 87.2M
Current Assets	CHF 91.5M
Current Liabilities	CHF 10.4M
Debt	CHF 3.4M
Debt Equity	CHF 0.05
Debt FCF	CHF -0.07
Equity	CHF 75.3M
Interest Coverage	-3,079.7
Liabilities	CHF 20.4M
Long Term Assets	CHF 4.2M
Long Term Liabilities	CHF 10M
Net Cash	CHF 83.8M
Net Cash By Market Cap	CHF 73.46
Net Cash Growth	-39.17%
Net Debt Equity	CHF -1.11
Tangible Book Value	CHF 75.3M
Tangible Book Value Per Share	CHF 2.01
WACC	8.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.79
Net Working Capital	CHF -5.6M
Quick ratio	8.56
Working Capital	CHF 80.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-5.97%
200-day SMA	3.24
3Y total return	-47.05%
50-day SMA	3.47
50-day SMA vs 200-day SMA	50over200
5Y total return	-85.18%
All Time High	29.75
All Time High Change	-89.14%
All Time High Date	2017-06-20
All Time Low	2.72
All Time Low Change	18.75%
All Time Low Date	2025-10-20
ATR	0.1
Beta	0.74
Ch YTD	-4.58
High	3.23
High52	3.94
High52 Date	2026-03-02
High52ch	-18.02%
Low	3.23
Low52	2.72
Low52 Date	2025-10-20
Low52ch	18.75%
Ma50ch	-6.84%
Price vs 200-day SMA	-0.25%
RSI	42.68
RSI Monthly	42.5
RSI Weekly	46.5
Sharpe ratio	-0.59x
Sortino ratio	-0.79
Total Return	-9.52%
Tr YTD	-4.58
Tr1m	0.16%
Tr1w	-4.15%
Tr3m	-7.98%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF -51.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,818,826%
Net Borrowing	-1,144,234.8
Shares Insiders	4.49%
Shares Institutions	8.22%
Shares Qo Q	0.04%
Shares Yo Y	9.52%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF -52.8M
Average Volume	2,057.15x
Bv Per Share	2.01
CAPEX	CHF -669,023
Ch1m	0.16
Ch1w	-4.15
Ch1y	-5.97
Ch3m	-7.98
Ch3y	-47.05
Ch5y	-85.18
Ch6m	-10.97
Change	-3%
Change From Open	0
Close	3.33
Days Gap	-3
Depreciation Amortization	846,847.1
Dollar Volume	914.1
Earnings Date	2026-08-25
EBIT	CHF -51.9M
EBITDA	CHF -51.1M
EPS	CHF -1.55
F Score	1
FCF	CHF -48.7M
FCF EV Yield	-164.18x
Financing CF	-1,076,621
Fiscal Year End	December
Founded	2,004
Income Tax	CHF 1,874
Investing CF	67,978,948
Is Primary Listing	0
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Ma150	3.2
Ma150ch	1%
Ma20	3.31
Ma20ch	-2.33%
Net CF	17,596,062
Next Earnings Date	2026-08-25
Open	3.23
Ppne	4,936,636.9
Price Date	2026-05-07
Ptbv Ratio	1.52
Relative Volume	0.14x
Share Based Comp	4,140,636
Tr6m	-10.97%
Volume	283

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0QXX pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0QXX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QXX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.2%

Share of float held by funds and institutions

Insider ownership

+4.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+9.5%

Negative means the company is buying back shares.

Technical

LON/0QXX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.7

Neutral momentum band

Price vs 200-day MA

-0.2%

50/200-day relationship not available

Beta (5Y)

0.74

Less volatile than the market

Sharpe ratio

-0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QXX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QXX stock rating?

lon/0QXX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QXX analysis?

The full report lives at /stocks/lon/0QXX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QXX?

The latest report frames lon/0QXX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QXX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.